Superstar @NYUnephro faculty @lamanazzal presenting on microbiome and CVD in CKD at AHA Scientific Sessions today
Possible future 3rd generation nephrologist attending ASN #prouddad
13
309
Neph folks-any luck in getting BAFF-APRIL inhibs approved without prior steroids trial?
IMO there is not rationale other than cost to require steroids or budes first-why not go straight to
More effective and better tolerated therapy
3
3
490
Another year in the books (almost)!
Good luck in future endeavors to another stellar group of @NYUnephro fellows!
1
14
1,577
Terrific medical grand round this morning by @benofreedman about renal organoids and cellular reprogramming for treatment of kidney diseases and beyond. Amazing work and vision. @NYUnephro @NYULH_DeptofMed
It was great to be back at #kidneywk. As always enjoyed reconnecting with colleagues and the science. A real downer being harassed for wearing a kippah by some locals on Friday night. Antisemitism alive and well again in USA in 2025.
1
8
988
David Charytan retweeted
Remembering and Honoring James Kaufman, MD
Dr. James Kaufman served as Associate Editor of the American Journal of Kidney Diseases for 19 years (2006-2025).
bit.ly/42boJHq
A new episode of Beyond our Role. Just dropped Listen Dr Ayotunde- stellar @NYUnephro fellow and her journey to nephrology open.spotify.com/episode/1dV…
2
315
Hey @TheDemocrats at what point is it time for the march on Washington?
2
295
Terrific @NYULH_DeptofMed MGR today on xenotransplantation and transplant tolerance by Dr Megan Sykes-an amazing body of work
I’m not arguing it couldn’t be done in theory. I’m asking what funding mechanism donor propose for this -who has a grant funded to do this -. Show me the rfa before you blindly critique all of academia for not doing this
Replying to @DCharytan @VPrasadMDMPH
No, it's not. Adil Shamoo, myself, and many other scholars working in the field of research integrity have argued for years that auditing data is one of the best ways to promote high quality science. It can be paid for through grant dollars.
1
503
David Charytan retweeted
In case RFK Jr convinced you that he is not anti-vax, but merely "skeptical" & concerned about vaccine safety...look here
NIH is terminating awards to obtain reliable data on vaccine hesitancy & ways to improve uptake. This is an explicitly anti-vax policy.
Link in reply👇
Would be nice id the law were upheld. Inside the Collapse at the NIH - The Atlantic theatlantic.com/health/archi…
264
David Charytan retweeted
Over the last 3 weeks you've heard countless scientists say that if we have budget cuts at NIH it will stop cancer cures and clinical trials. This study was funded by the NIH. The control arm should be getting active anti-cancer therapy, many did not get it, and many got it only after the trial, when their disease was worse. The government is funding a study that lets cancer patients die slowly without getting appropriate care. It's unethical. It's disgusting. And worst of all it's an abuse of taxpayer money. Many of the defenders of the current system do not actually understand just how pervasive the rot is. Scientists lost your trust during the pandemic, but the truth is in many fields they didn't deserve it in the first place. This is the kind of stuff they're doing. Side note: this trial also has inappropriate use of crossover. You can learn more about its errors in my book Malignant written in 2020 #doge
Original Article: Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors (CABINET trial) nej.md/3AYuEoI
#Gastroenterology

ALT A graph showing progression-free survival, as assessed retrospectively by blinded independent central review according to RECIST 1.1 (two-sided stratified log-rank P<0.001 for the comparison between the cabozantinib and placebo groups), among patients in the pancreatic neuroendocrine tumors cohort.
David Charytan retweeted
Really excited about our new work describing how we disseminated kidney palliative care to a safety net setting.
Implementation of Ambulatory Kidney Supportive Care in a Safety Net Hospital - Journal of Pain and Symptom Management jpsmjournal.com/article/S088…



















